These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1057355)

  • 21. A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.
    Cooper MR; Pajak TF; Nissen NI; Stutzman L; Brunner K; Cuttner J; Falkson G; Grunwald H; Bank A; Leone L; Seligman BR; Silver RT; Weiss RB; Haurani F; Blom J; Spurr CL; Glidewell OJ; Gottlieb AJ; Holland JF
    Cancer; 1980 Aug; 46(4):654-62. PubMed ID: 7397630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy of malignant lymphomas.
    Kärcher KH; Jentzsch K
    Acta Neuropathol Suppl; 1975; Suppl 6():217-20. PubMed ID: 1057354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The so-called partial synchronization in the treatment of malignant lymphomas. A clinical study].
    Höche D; Fink R; Anger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):13-26. PubMed ID: 6157615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
    Bonadonna G
    Cancer Res; 1982 Nov; 42(11):4309-20. PubMed ID: 6181867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European experience with ifosfamide in lymphomas.
    von Kalle AK; Schaadt M; Diehl V
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
    Bonadonna G; Santoro A; Bonfante V; Valagussa P
    Cancer Treat Rep; 1982 Apr; 66(4):881-7. PubMed ID: 6176323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternating drug combinations in the treatment of advanced Hodgkin's disease.
    Santoro A; Bonadonna G; Bonfante V; Valagussa P
    N Engl J Med; 1982 Apr; 306(13):770-5. PubMed ID: 6174865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
    Krikorian JG; Portlock CS; Rosenberg SA
    Cancer; 1978 Jun; 41(6):2107-11. PubMed ID: 77716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ Long-term evaluation of the effect of a chemotherapy protocol using vincristine, adriamycin, procarbazine and prednisone (VAPP) on advanced Hodgkin's disease].
    Marinone G; Colle R; Mombelloni P
    Minerva Med; 1978 Apr; 69(18):1255-61. PubMed ID: 662153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
    van den Berg H; Stuve W; Behrendt H
    Med Pediatr Oncol; 1997 Jul; 29(1):23-7. PubMed ID: 9142201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
    Diggs CH; Wiernik PH; Levi JA; Kvols LK
    Cancer; 1977 May; 39(5):1949-54. PubMed ID: 870162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prospective study on remission induction and maintenance in malignant lymphomas].
    Malchow H; Buchelt L; Gassel WD; Joseph K; Schultz H; Schmidt M; Sodomann CP; Havemann K
    Verh Dtsch Ges Inn Med; 1974; 80():1689-93. PubMed ID: 4454515
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group.
    Glick JH; Barnes JM; Bakemeier RF; Prosnitz LR; Bennett JM; Neiman RS; Costello W; Orlow EL
    Cancer Treat Rep; 1982 Apr; 66(4):855-70. PubMed ID: 7042087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapy in non-Hodgkin's lymphomas (author's transl)].
    Schmidt CG
    Strahlentherapie; 1977 May; 153(5):283-92. PubMed ID: 69343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in the chemotherapy of hematologic diseases.
    Frei E
    Bibl Haematol; 1975; (40):27-43. PubMed ID: 51622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemotherapy with VM-26, adriamycin bleomycin, and prednisone as a secondary treatment of malignant lymphoma.
    Goldhirsch A; Pirovino M; Sonntag RW; Tschopp L; Ryssel HJ; Brunner KW
    Cancer Treat Rep; 1980; 64(2-3):335-7. PubMed ID: 6157468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of maintenance MOPP/COPP treatment on the number and function of peripheral T- and B-lymphocytes in Hodgkin's disease during remission].
    Płuzańska A; Kałuzna W
    Pol Arch Med Wewn; 1981 Jun; 65(6):475-81. PubMed ID: 6973752
    [No Abstract]   [Full Text] [Related]  

  • 39. Combination chemotherapy for stage IV Hodgkin's disease (Report no 14).
    Goldman JM
    Clin Radiol; 1981 Sep; 32(5):531-6. PubMed ID: 6168426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of radiotherapy and chemotherapy in the treatment of lymphomas.
    Ramot B; Ben-Bassat I
    Bull World Health Organ; 1979; 57(6):857-63. PubMed ID: 317017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.